Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DROMOSTANOLONE Cause Secondary hypogonadism? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Secondary hypogonadism have been filed in association with DROMOSTANOLONE. This represents 14.1% of all adverse event reports for DROMOSTANOLONE.

10
Reports of Secondary hypogonadism with DROMOSTANOLONE
14.1%
of all DROMOSTANOLONE reports
0
Deaths
10
Hospitalizations

How Dangerous Is Secondary hypogonadism From DROMOSTANOLONE?

Of the 10 reports, 10 (100.0%) required hospitalization.

Is Secondary hypogonadism Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DROMOSTANOLONE. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does DROMOSTANOLONE Cause?

Drug abuse (31) Intentional product misuse (16) Autoimmune thyroiditis (9) Diabetes mellitus (9) Multiple organ dysfunction syndrome (9) Hepatic neoplasm (8) Poisoning (8) Haematocrit increased (7) Intra-abdominal haemorrhage (7) Nephropathy (7)

What Other Drugs Cause Secondary hypogonadism?

TESTOSTERONE (39) FINASTERIDE (38) PREDNISONE (23) ANASTROZOLE (20) DUPILUMAB (20) MIRTAZAPINE (20) OMALIZUMAB (20) FLUTICASONE FUROATE (19) TIOTROPIUM (18) VILANTEROL (18)

Related Pages

DROMOSTANOLONE Full Profile All Secondary hypogonadism Reports All Drugs Causing Secondary hypogonadism DROMOSTANOLONE Demographics